Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Oktober 2022 08:00 ET | Quelle: Sema4

Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study

STAMFORD, Conn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced it is a partner in the recently launched GUARDIAN study (Genomic Uniform-screening...
03. Oktober 2022 08:00 ET | Quelle: AM FRESH GROUP FAST MOVING CONSUM GOODS, S.L.

AM FRESH Group acquires a controlling interest of Fruit-X to spearhead varietal innovation and redefine the produce experience in Asia; The company will be rebranded FRESH FRUIT-X

MADRID, Spain, Oct. 03, 2022 (GLOBE NEWSWIRE) -- AM FRESH Group, a leading global company in genetics, agri-tech and farming has acquired a majority stake in Asian-based Fruit-X to redefine the...
19. September 2022 15:57 ET | Quelle: Howard University

Howard University Awarded $11.5 Million From Chan Zuckerberg Initiative To Expand Genomics And Genetics Research Capacity

WASHINGTON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Today, the Chan Zuckerberg Initiative (CZI) announced a partnership with Howard University and the nation’s three other historically Black medical...
23. August 2022 15:35 ET | Quelle: Straits Research

Pharmacogenomics Market Size is projected to reach USD 11.79 Billion by 2030, growing at a CAGR of 8.47%: Straits Research

New York, USA, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The global pharmacogenomics market is expected to grow due to the constantly rising need for treating fatal diseases like cancer and increasing...
16. August 2022 01:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe

Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing international lab partner program SALT LAKE CITY, Aug....
30. Juni 2022 09:48 ET | Quelle: The Insight Partners

Genotyping Market Size Worth $79.4Bn by 2028 at 20.1% CAGR, Colossal Market Share (by F. Hoffmann-La Roche Ltd. & Illumina, Inc.), Lead by Product and Services Segment, Deep Dive Global Analysis by The Insight Partners

New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service...
26. Mai 2022 08:00 ET | Quelle: Sema4

Sema4 to Participate at Two Investor Conferences in June 2022

STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
23. Mai 2022 08:00 ET | Quelle: Meticulous Market Research Pvt. Ltd.

Veterinary Molecular Diagnostics Market Worth $1.61 Billion by 2029 - Exclusive Report by Meticulous Research®

Redding, California, May 23, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, “Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, System & Software),...
10. Mai 2022 10:30 ET | Quelle: National Coordinating Center for the Regional Genetics Network

The Third Annual Public Health Genetics Week is Around the Corner - May 23-27, 2022

BETHESDA, Md., May 10, 2022 (GLOBE NEWSWIRE) -- The National Coordinating Center for the Regional Genetics Network (NCC) is excited to announce that the third annual Public Health Genetics Week will...
04. Mai 2022 16:05 ET | Quelle: Sema4

Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...

Vorherige Seite

Nächste Seite